BioMarin off 17% as Ascendis data seen as threat to Voxzogo Source: Seekingalpha
Browsing: Ascendis
Ascendis gets FDA orphan drug status for Yorvipath for hypothyroidism Source: Seekingalpha
Iryna Drozd The FDA has granted Orphan Drug Designation to Ascendis Pharma (ASND) for its prodrug Yorvipath for the therapy of hypothyroidism in adults. Yorvipath is…
Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha
Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha
Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha
Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha